BioBanking as the central tool for translational medicine CTM issue 2013

by György Marko‐Varga
Published 2013-12-01

EuPA’s tribute to Juan Pablo Albar

by Concha Gil, Fernando Corrales, Garry Corthals, György Marko-Varga, Peter Verhaert
Published 2015-09-01

Non-invasive skin sampling of tryptophan/kynurenine ratio in vitro towards a skin cancer biomarker

by Skaidre Jankovskaja, Johan Engblom, Melinda Rezeli, György Marko-Varga, Tautgirdas Ruzgas, Sebastian Björklund
Published 2021-01-01

Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue.

by Jimmy Rodriguez Murillo, Magdalena Kuras, Melinda Rezeli, Tasso Miliotis, Lazaro Betancourt, Gyorgy Marko-Varga
Published 2018-01-01

Correction: Automated phosphopeptide enrichment from minute quantities of frozen malignant melanoma tissue.

by Jimmy Rodriguez Murillo, Magdalena Kuras, Melinda Rezeli, Tasso Miliotis, Lazaro Betancourt, Gyorgy Marko-Varga
Published 2018-01-01

Quantification of total apolipoprotein E and its specific isoforms in cerebrospinal fluid and blood in Alzheimer’s disease and other neurodegenerative diseases

by Melinda Rezeli, Henrik Zetterberg, Kaj Blennow, Ann Brinkmalm, Thomas Laurell, Oskar Hansson, György Marko-Varga
Published 2015-09-01

Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

by Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, György Marko-Varga, Roland Andersson, Daniel Ansari
Published 2017-12-01

Biobank integration of large-scale clinical and histopathology melanoma studies within the European Cancer Moonshot Lund Center

by Johan Malm, Yutaka Sugihara, Marcell Szasz, Ho Jeong Kwon, Henrik Lindberg, Roger Appelqvist, György Marko-Varga
Published 2018-08-01

Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development

by Melinda Rezeli, Ákos Végvári, Edina Silajdžić, Maria Björkqvist, Sarah J. Tabrizi, Thomas Laurell, György Marko-Varga
Published 2014-06-01

Intra-tumour IgA1 is common in cancer and is correlated with poor prognosis in bladder cancer.

by Charlotte Welinder, Karin Jirström, Sophie Lehn, Björn Nodin, György Marko-Varga, Ola Blixt, Lena Danielsson, Bo Jansson
Published 2016-08-01

Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry.

by Anna Nilsson, Thomas E Fehniger, Lena Gustavsson, Malin Andersson, Kerstin Kenne, György Marko-Varga, Per E Andrén
Published 2010-07-01

Workflow for large-scale analysis of melanoma tissue samples

by Maria E. Yakovleva, Charlotte Welinder, Yutaka Sugihara, Krzysztof Pawłowski, Melinda Rezeli, Elisabet Wieslander, Johan Malm, György Marko-Varga
Published 2015-09-01

Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker

by Johannes Byrling, Theresa Kristl, Dingyuan Hu, Indira Pla, Aniel Sanchez, Agata Sasor, Roland Andersson, György Marko-Varga, Bodil Andersson
Published 2020-09-01

Understanding drug uptake and binding within targeted disease micro‐environments in patients: a new tool for translational medicine

by György Marko‐Varga, Ákos Végvári, Melinda Rezeli, Kaiu Prikk, Peeter Ross, Magnus Dahlbäck, Goutham Edula, Ruth Sepper, Thomas E Fehniger
Published 2012-12-01

Semi‐automated biobank sample processing with a 384 high density sample tube robot used in cancer and cardiovascular studies

by Johan Malm, Henrik Lindberg, David Erlinge, Roger Appelqvist, Maria Yakovleva, Charlotte Welinder, Erik Steinfelder, Thomas E Fehniger, György Marko‐Varga
Published 2015-12-01

Amyloid-specific extraction using organic solvents

by Junichi Kamiie, Naoyuki Aihara, Yu Uchida, Daiki Kobayashi, Yutaka Yoshida, Takeshi Kuroda, Motoharu Sakaue, Yutaka Sugihara, Melinda Rezeli, György Marko-Varga
Published 2020-01-01

Matrix‐assisted laser desorption ionization ‐ mass spectrometry imaging of erlotinib reveals a limited tumor tissue distribution in a non‐small‐cell lung cancer mouse xenograft mod...

by Tae Young Kim, Boram Lee, Yonghyo Kim, Yutaka Sugihara, Melinda Rezeli, A. Marcell Szasz, Balazs Dome, Gyorgy Marko‐Varga, Ho Jeong Kwon
Published 2021-07-01

Proteomic analysis enables distinction of early‐ versus advanced‐stage lung adenocarcinomas

by Olga Kelemen, Indira Pla, Aniel Sanchez, Melinda Rezeli, Attila Marcell Szasz, Johan Malm, Viktoria Laszlo, Ho Jeong Kwon, Balazs Dome, Gyorgy Marko‐Varga
Published 2020-06-01

Merging clinical chemistry biomarker data with a COPD database - building a clinical infrastructure for proteomic studies

by Jonatan Eriksson, Simone Andersson, Roger Appelqvist, Elisabet Wieslander, Mikael Truedsson, May Bugge, Johan Malm, Magnus Dahlbäck, Bo Andersson, Thomas E. Fehniger, György Marko-Varga
Published 2017-04-01

Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability

by Charlotte Welinder, Göran Jönsson, Christian Ingvar, Lotta Lundgren, Håkan Olsson, Thomas Breslin, Ákos Végvári, Thomas Laurell, Melinda Rezeli, Bo Jansson, Bo Baldetorp, György Marko‐Varga
Published 2013-12-01